240 related articles for article (PubMed ID: 32189192)
1. Human CYP2D6 Is Functional in Brain In Vivo: Evidence from Humanized CYP2D6 Transgenic Mice.
Tolledo C; Stocco MR; Miksys S; Gonzalez FJ; Tyndale RF
Mol Neurobiol; 2020 Jun; 57(6):2509-2520. PubMed ID: 32189192
[TBL] [Abstract][Full Text] [Related]
2. Propranolol is a mechanism-based inhibitor of CYP2D and CYP2D6 in humanized CYP2D6-transgenic mice: Effects on activity and drug responses.
Tolledo EC; Miksys S; Gonzalez FJ; Tyndale RF
Br J Pharmacol; 2020 Feb; 177(3):701-712. PubMed ID: 31648367
[TBL] [Abstract][Full Text] [Related]
3. Human CYP2D6 in the Brain Is Protective Against Harmine-Induced Neurotoxicity: Evidence from Humanized CYP2D6 Transgenic Mice.
Stocco MR; Tolledo C; Wadji FB; Gonzalez FJ; Miksys S; Tyndale RF
Mol Neurobiol; 2020 Nov; 57(11):4608-4621. PubMed ID: 32761352
[TBL] [Abstract][Full Text] [Related]
4. Human CYP2D6 and mouse CYP2Ds: organ distribution in a humanized mouse model.
Miksys SL; Cheung C; Gonzalez FJ; Tyndale RF
Drug Metab Dispos; 2005 Oct; 33(10):1495-502. PubMed ID: 16033950
[TBL] [Abstract][Full Text] [Related]
5. Rat brain CYP2D enzymatic metabolism alters acute and chronic haloperidol side-effects by different mechanisms.
Miksys S; Wadji FB; Tolledo EC; Remington G; Nobrega JN; Tyndale RF
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Aug; 78():140-148. PubMed ID: 28454738
[TBL] [Abstract][Full Text] [Related]
6. The roles of Cyp1a2 and Cyp2d in pharmacokinetic profiles of serotonin and norepinephrine reuptake inhibitor duloxetine and its metabolites in mice.
Qin X; Xie C; Hakenjos JM; MacKenzie KR; Boyd SR; Barzi M; Bissig KD; Young DW; Li F
Eur J Pharm Sci; 2023 Feb; 181():106358. PubMed ID: 36513193
[TBL] [Abstract][Full Text] [Related]
7. The role of CYP2D in rat brain in methamphetamine-induced striatal dopamine and serotonin release and behavioral sensitization.
Stocco MR; El-Sherbeni AA; Zhao B; Novalen M; Tyndale RF
Psychopharmacology (Berl); 2021 Jul; 238(7):1791-1804. PubMed ID: 33649968
[TBL] [Abstract][Full Text] [Related]
8. Potential role of CYP2D6 in the central nervous system.
Cheng J; Zhen Y; Miksys S; Beyoğlu D; Krausz KW; Tyndale RF; Yu A; Idle JR; Gonzalez FJ
Xenobiotica; 2013 Nov; 43(11):973-84. PubMed ID: 23614566
[TBL] [Abstract][Full Text] [Related]
9. The CYP2D6 humanized mouse: effect of the human CYP2D6 transgene and HNF4alpha on the disposition of debrisoquine in the mouse.
Corchero J; Granvil CP; Akiyama TE; Hayhurst GP; Pimprale S; Feigenbaum L; Idle JR; Gonzalez FJ
Mol Pharmacol; 2001 Dec; 60(6):1260-7. PubMed ID: 11723233
[TBL] [Abstract][Full Text] [Related]
10. Catalytic specificity of CYP2D isoforms in rat and human.
Hiroi T; Chow T; Imaoka S; Funae Y
Drug Metab Dispos; 2002 Sep; 30(9):970-6. PubMed ID: 12167561
[TBL] [Abstract][Full Text] [Related]
11. First demonstration that brain CYP2D-mediated opiate metabolic activation alters analgesia in vivo.
Zhou K; Khokhar JY; Zhao B; Tyndale RF
Biochem Pharmacol; 2013 Jun; 85(12):1848-55. PubMed ID: 23623752
[TBL] [Abstract][Full Text] [Related]
12. Chronic nicotine treatment induces rat CYP2D in the brain but not in the liver: an investigation of induction and time course.
Yue J; Miksys S; Hoffmann E; Tyndale RF
J Psychiatry Neurosci; 2008 Jan; 33(1):54-63. PubMed ID: 18197273
[TBL] [Abstract][Full Text] [Related]
13. Regional and cellular distribution of CYP2D subfamily members in rat brain.
Miksys S; Rao Y; Sellers EM; Kwan M; Mendis D; Tyndale RF
Xenobiotica; 2000 Jun; 30(6):547-64. PubMed ID: 10923858
[TBL] [Abstract][Full Text] [Related]
14. Sex hormones regulate cerebral drug metabolism via brain miRNAs: down-regulation of brain CYP2D by androgens reduces the analgesic effects of tramadol.
Li J; Xie M; Wang X; Ouyang X; Wan Y; Dong G; Yang Z; Yang J; Yue J
Br J Pharmacol; 2015 Oct; 172(19):4639-54. PubMed ID: 26031356
[TBL] [Abstract][Full Text] [Related]
15. Modeling human cytochrome P450 2D6 metabolism and drug-drug interaction by a novel panel of knockout and humanized mouse lines.
Scheer N; Kapelyukh Y; McEwan J; Beuger V; Stanley LA; Rode A; Wolf CR
Mol Pharmacol; 2012 Jan; 81(1):63-72. PubMed ID: 21989258
[TBL] [Abstract][Full Text] [Related]
16. Effects of monoamine oxidase inhibitor and cytochrome P450 2D6 status on 5-methoxy-N,N-dimethyltryptamine metabolism and pharmacokinetics.
Shen HW; Wu C; Jiang XL; Yu AM
Biochem Pharmacol; 2010 Jul; 80(1):122-8. PubMed ID: 20206139
[TBL] [Abstract][Full Text] [Related]
17. Sex steroid hormones differentially regulate CYP2D in female wild-type and CYP2D6-humanized mice.
Konstandi M; Andriopoulou CE; Cheng J; Gonzalez FJ
J Endocrinol; 2020 May; 245(2):301-314. PubMed ID: 32171179
[TBL] [Abstract][Full Text] [Related]
18. Selective deficiency of debrisoquine 4-hydroxylase activity in mouse liver microsomes.
Masubuchi Y; Iwasa T; Hosokawa S; Suzuki T; Horie T; Imaoka S; Funae Y; Narimatsu S
J Pharmacol Exp Ther; 1997 Sep; 282(3):1435-41. PubMed ID: 9316857
[TBL] [Abstract][Full Text] [Related]
19. Impact of CYP2D6 poor metabolizer phenotype on propranolol pharmacokinetics and response.
Sowinski KM; Burlew BS
Pharmacotherapy; 1997; 17(6):1305-10. PubMed ID: 9399616
[TBL] [Abstract][Full Text] [Related]
20. The Involvement of PPARs in the Selective Regulation of Brain CYP2D by Growth Hormone.
Zhang F; Li J; Na S; Wu J; Yang Z; Xie X; Wan Y; Li K; Yue J
Neuroscience; 2018 May; 379():115-125. PubMed ID: 29555426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]